W2RhdGEtdG9vbHNldC1ibG9ja3MtaW1hZ2U9ImYzN2UwMzE4MzUyYWY0NWU4NmQwNzAyOGRkNTA4M2Y3Il0geyBtYXgtd2lkdGg6IDEwMCU7IH0gW2RhdGEtdG9vbHNldC1ibG9ja3MtaW1hZ2U9ImYzN2UwMzE4MzUyYWY0NWU4NmQwNzAyOGRkNTA4M2Y3Il0gaW1nIHsgYm94LXNoYWRvdzogMXB4IDFweCAxMHB4IDVweCByZ2JhKCAwLCAwLCAwLCAwLjEgKTtib3JkZXItcmFkaXVzOiAwO2JhY2tncm91bmQtY29sb3I6IHJnYmEoIDI1NSwgMjU1LCAyNTUsIDEgKTtwYWRkaW5nOiAyMHB4O2JvcmRlcjogMHB4IHNvbGlkIHJnYmEoIDAsIDAsIDAsIDAuMjUgKTsgfSA=
W2RhdGEtdG9vbHNldC1ibG9ja3MtaW1hZ2U9ImYzN2UwMzE4MzUyYWY0NWU4NmQwNzAyOGRkNTA4M2Y3Il0geyBtYXgtd2lkdGg6IDEwMCU7IH0gW2RhdGEtdG9vbHNldC1ibG9ja3MtaW1hZ2U9ImYzN2UwMzE4MzUyYWY0NWU4NmQwNzAyOGRkNTA4M2Y3Il0gaW1nIHsgYm94LXNoYWRvdzogMXB4IDFweCAxMHB4IDVweCByZ2JhKCAwLCAwLCAwLCAwLjEgKTtib3JkZXItcmFkaXVzOiAwO2JhY2tncm91bmQtY29sb3I6IHJnYmEoIDI1NSwgMjU1LCAyNTUsIDEgKTtwYWRkaW5nOiAyMHB4O2JvcmRlcjogMHB4IHNvbGlkIHJnYmEoIDAsIDAsIDAsIDAuMjUgKTsgfSA=
Safe Equine Technologies (“SET”) is partnered with New Horizons Diagnostics, (“NHD”) and is a narrow focus biotechnology company that develops and commercializes diagnostics and therapeutics to safeguard the health of the equine population. Their products are currently in the final stages of development and are based upon two principal technologies – bacteriophage derived lytic enzymes (lysins or PlyC) and immunochromatographic lateral flow diagnostics.
